首页|益气活血通络汤联合丁苯酞治疗脑梗死恢复期患者的效果

益气活血通络汤联合丁苯酞治疗脑梗死恢复期患者的效果

扫码查看
目的:观察益气活血通络汤联合丁苯酞治疗脑梗死恢复期患者的效果.方法:选取 2019 年 2 月至 2022 年 2 月该院收治的75 例脑梗死恢复期患者进行前瞻性研究,按照随机数字表法将其分为研究组 38 例与对照组 37 例.对照组采用丁苯酞软胶囊治疗,研究组在对照组基础上联合益气活血通络汤治疗.比较两组临床疗效、治疗前后日常生活能力[Barthel指数(BI)]评分、肢体运动功能[Fugl-Meyer运动功能量表(FMA)]评分、神经功能相关指标[改良Rankin量表(MRS)、中枢神经特异性蛋白(S100β)]水平、脑血流动力学指标[大脑前动脉(ACA)、基底动脉(BA)血流速度]水平及不良反应发生率.结果:研究组治疗总有效率为 94.74%(36/38),高于对照组的75.68%(28/37),差异有统计学意义(P<0.05);治疗后,两组BI、FMA评分均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组MRS评分和S100β水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组ACA、BA血流速度均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:益气活血通络汤联合丁苯酞治疗脑梗死恢复期患者可提高治疗总有效率、BI评分、FMA评分和脑血流动力学指标水平,降低神经功能相关指标水平,其效果优于单纯丁苯酞软胶囊治疗.
Effects of Yiqi Huoxue Tongluo decoction combined with Butylphthalide in treatment of convalescent patients with cerebral infarction
Objective:To observe the effect of Yiqi Huoxue Tongluo decoction combined with Butylphthalide in treatment of convalescent patients with cerebral infarction.Methods:A prospective study was conducted on 75 convalescent patients with cerebral infarction admitted to the hospital from February 2019 to February 2022.According to the random number table method,they were divided into study group(38 cases)and control group(37 cases).The control group was treated with Butylphthalide soft capsules,while the study group was treated with Yiqi Huoxue Tongluo decoction on the basis of that of the control group.The clinical efficacy,the daily living ability[Barthel index(BI)]score,the limb motor function[Fugl-Meyer assessment(FMA)]score,the neurological function related indicators[modified Rankin scale(MRS),central nervous specific protein(S100β)]levels,the cerebral hemodynamic indicators[anterior cerebral artery(ACA),basilar artery(BA)blood flow velocity]levels,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 94.74%(36/38),which was higher than 75.68%(28/37)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the BI and FMA scores of the two groups were higher than those before the treatment,those of the study group were higher than those of the control group,and the differences were statistically significant(P<0.05).The MRS scores and the S100β levels of the two groups were lower than those before treatment,those of the study group were lower than those of the control group,and the differences were statistically significant(P<0.05).The blood flow velocities of ACA and BA in the two groups were higher than those before the treatment,those of the study group were higher than those of the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Yiqi Huoxue Tongluo decoction combined with Butylphthalide in the treatment of the convalescent patients with cerebral infarction can improve the total effective rate of treatment,the BI scores,the FMA scores and the cerebral hemodynamic indicator level,and reduce the levels of neurological function related indicators.Moreover,it is superior to single Butylphthalide soft capsules treatment.

Yiqi Huoxue Tongluo decoctionButylphthalideCerebral infarction recovery periodNeurological functionCerebral hemodynamicsAdverse reaction

史付鑫

展开 >

南阳医专附属中医院内一科,河南 南阳 473000

益气活血通络汤 丁苯酞 脑梗死恢复期 神经功能 脑血流动力学 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(3)
  • 14